Announced Mon, 13 Apr · 19:55 IST

Healthcare Global Enterprises Limited (the Company) has informed the Exchange about completion of acquisition of additional 34% shares of Vizag Hospital and Cancer Research Centre Private Limited (Vizag Hospital). With this acquisition, the Company holds 85% equity share capital of Vizag Hospital.

Listed Co AcquisitionStrategic Transactions View source PDF

HCG · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.7%1-day move
₹552.00
prior close
₹563.95
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.0-2.2-1.8-1.1+2.7+2.5+3.3+4.0+5.1+3.8+10.3+15.4+13.8+17.1
Up moveDown movePending
AI summary

HCG has completed acquisition of an additional 34% stake (1,93,441 equity shares) in Vizag Hospital and Cancer Research Centre Private Limited for INR 154.5 crore. The acquisition was done pursuant to a Share Purchase Agreement and Shareholders' Agreement entered on June 28, 2024, with amendments on October 1, 2024 and March 29, 2026. Following this completion, HCG now holds 85% equity share capital of Vizag Hospital, up from 51% previously held. This represents a staged acquisition process that has now reached a controlling majority position.

Likely market impact

HCG has strengthened its control over Vizag Hospital, increasing ownership to 85%, which will allow greater consolidation of revenues and operational control of this cancer care facility. The deal signals continued expansion in the oncology healthcare segment.